0 items USD 0.00Search
- Did you mean
- closing spondylitis
Your search for "Ankylosing spondylitis" gave back 122 results.
The global Ankylosing Spondylitis Drug market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of...
Catalog:
MRRPB5
February 2024
Price: USD 2,900.00
Ankylosing Spondylitis Medication is a drug used to relieve or treat ankylosing spondylitis. The “Ankylosing Spondylitis Medication Industry Forecast...
Catalog:
LPI
February 2023
Price: USD 3,660.00
The “Ankylosing Spondylitis Drug Industry Forecast” looks at past sales and reviews total world Ankylosing Spondylitis Drug sales in 2022, providing...
Catalog:
LPI
March 2023
Price: USD 3,660.00
The “Ankylosing Spondylitis Treatment Drug Industry Forecast” looks at past sales and reviews total world Ankylosing Spondylitis Treatment Drug sales...
Catalog:
LPI
March 2023
Price: USD 3,660.00
Ankylosing spondylitis is a chronic inflammatory disease that affects the spine. It is a type of arthritis, in which spine bones grow or fuse...
Catalog:
LPI
February 2023
Price: USD 3,660.00
Summary Ankylosing Spondylitis market research report provides the newest industry data and industry future trends, allowing you to identify the...
Catalog:
ICRW
January 2024
Price: USD 2,960.00
Highlights The global Ankylosing Spondylitis Drug market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029,...
Catalog:
MRRPB5
April 2023
Price: USD 2,900.00
Ankylosing spondylitis is a chronic inflammatory disease that affects the spine. It is a type of arthritis, in which spine bones grow or fuse...
Catalog:
MRRPB5
February 2023
Price: USD 2,900.00
Summary Ankylosing Spondylitis market research report provides the newest industry data and industry future trends, allowing you to identify the...
Catalog:
ICRW
December 2020
Price: USD 2,960.00
Summary HeyReport estimates that the Musculoskeletal Disorders Drugs market size will grow from xxx Million USD in 2020 to xxxx Million USD by 2025,...
Catalog:
HYR
July 2021
Price: USD 2,000.00
Summary The Musculoskeletal Disorders Drugs market size will grow from xxx Million USD in 2020 to xxxx Million USD by 2025, and with a CAGR of xx%...
Catalog:
HYR
March 2021
Price: USD 2,000.00
The global Humira market size was valued at USD 17560 million in 2023 and is forecast to a readjusted size of USD 9840.6 million by 2030 with a CAGR...
Catalog:
GIR
January 2024
Price: USD 3,480.00
Humira (adalimumab) is a tumor necrosis factor (TNF) blocker that reduces the effects of a substance in the body that can cause inflammation. Humira...
Catalog:
LPI
January 2023
Price: USD 3,660.00
The global Humira market size was valued at US$ 16700 million in 2023. With growing demand in downstream market, the Humira is forecast to a...
Catalog:
LPI
January 2024
Price: USD 3,660.00
Humira (adalimumab) is a tumor necrosis factor (TNF) blocker that reduces the effects of a substance in the body that can cause inflammation. Humira...
Catalog:
GIR
April 2023
Price: USD 3,480.00
